Associate Director / Director, Signatera Emerging Indications
Natera- Full Time
- Senior (5 to 8 years)
Employment Type: Full time
At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world-changing projects, you will do more and become more than you ever thought possible.
Illumina, Inc. is seeking a board-certified clinical laboratory molecular geneticist with experience in hereditary disease screening and diagnostic genetic testing. This position is part of the Global Medical Affairs organization, reporting to the Senior Director of Medical Affairs, AMR Hereditary Disease at Illumina. This role will have the responsibility for executing the medical affairs strategy in the United States in close coordination with the company’s strategic goals. The individual in this role will represent Medical Affairs within cross-functional teams focused on hereditary disease and reproductive genetics, working closely with Commercial, Business Development, Pharma, R&D, Product Marketing, Regulatory, Bioinformatics, Assay Development, and Quality teams. This position is also responsible for medical research and evidence generation in hereditary disease to drive broader adoption of genomics in healthcare, supporting commercial team strategies with medical affairs resources, providing scientific education on hereditary disease genomics, and influencing product development for hereditary disease genomics.
The ideal candidate would have a history of successful impact at clinical genomics laboratories utilizing next-generation sequencing technologies for hereditary disease screening or diagnostics. It is important that the candidate has had experience and interest in operating at the intersection of medical and commercial activities. This candidate has a background in molecular and cytogenetic methods used for hereditary disease genetic screening and diagnostics, including for reproductive carrier screening, non-invasive prenatal screening, prenatal diagnostic genetic testing, congenital genetic disorders, neurological genetic disorders, hereditary cancer, cardiovascular disorders, metabolic disorders, rare disease, and pharmacogenetics. The candidate must have a solid understanding of the trends in professional practice in medical genetics in the United States and a wide network of connections with key opinion leaders. The candidate must have demonstrably deep understanding of the trends in next-generation sequencing, clinical laboratory practices and their regulatory oversight, and technologies broadly deployed in hereditary disease genetic screening and diagnostics. The candidate must have a strong record of research and publications in hereditary disease.
At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.